Stereotactic Body Radiotherapy (SBRT) to Localised Prostate Cancer in the Era of MRI-Guided Adaptive Radiotherapy: Doses Delivered in the HERMES Trial Comparing Two- and Five-Fraction Treatments.

Saved in:
Bibliographic Details
Title: Stereotactic Body Radiotherapy (SBRT) to Localised Prostate Cancer in the Era of MRI-Guided Adaptive Radiotherapy: Doses Delivered in the HERMES Trial Comparing Two- and Five-Fraction Treatments.
Authors: Westley, Rosalyne1,2 (AUTHOR) rosalyne@doctors.org.uk, Casey, Francis3 (AUTHOR), Mitchell, Adam3 (AUTHOR), Alexander, Sophie1,2 (AUTHOR), Nill, Simeon3 (AUTHOR), Murray, Julia1,2 (AUTHOR), Ratnakumaran, Ragu1,2 (AUTHOR), Pathmanathan, Angela1,2 (AUTHOR), Oelfke, Uwe3 (AUTHOR), Dunlop, Alex3 (AUTHOR), Tree, Alison C.1,2 (AUTHOR) rosalyne@doctors.org.uk
Source: Cancers. Jun2024, Vol. 16 Issue 11, p2073. 15p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:20726694
DOI:10.3390/cancers16112073